¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"State cancer registry"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • carrier state
    º¸±Õ»óÅÂ
  • central excitatory state
    ÁßÃßÈïºÐ»óÅÂ
  • dynamic state
    ¿ªµ¿»óÅÂ
  • dormant state
    Àẹ»óÅÂ, ÀáÀç»óÅÂ, ÈÞ¸é»óÅÂ
  • dreamy state
    ¸ù·Õ»óÅÂ
  • febrile state
    ¹ß¿­»óÅÂ
  • ground state
    ¹Ù´Ú»óÅÂ, ±âÀú»óÅÂ
  • hypercoagulable state
    ÀÀ°íÇ×Áø»óÅÂ
  • hyperdynamic state
    °ú¿ªµ¿»óÅÂ
  • hypnagogic state
    ÀÔ¸é»óÅÂ
  • hypnopompic state
    Ãâ¸é»óÅÂ
  • hydration state
    ¼öÈ­»óÅÂ
  • integrated state
    ÅëÇÕ»óÅÂ
  • local excitatory state
    ±¹¼ÒÈïºÐ»óÅÂ
  • mini-mental state examination
    °£ÀÌÁ¤½Å»óŰ˻ç
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • dynamic state
    µ¿Àû»óÅÂ
  • eunuchoid state
    °íÀÚ´àÀº»óÅÂ
  • excitation state
    ÈïºÐ»óÅÂ
  • mini-mental state examination
    °£ÀÌÁ¤½Å»óŰ˻ç
  • solid state electrode
    °íüÀü±Ø
  • febrile state
    À¯¿­»óÅÂ
  • ground state
    ±âÀú»óÅÂ
  • hepatitis carrier state
    °£¿°º¸±ÕÀÚ»óÅÂ
  • hydration state
    ¼öÈ­»óÅÂ
  • hypercoagulable state
    °ú´ÙÀÀ°í»óÅÂ
  • hyperdynamic state
    °ú¿ªµ¿»óÅÂ
  • hyperimmune state
    °í¸é¿ª»óÅÂ
  • hyperkinetic circulatory state
    ¿îµ¿°ú´Ù¼øÈ¯»óÅÂ
  • hypnagogic state
    ÀÔ¸é»óÅÂ
  • hypnoidal state
    ÃÖ¸éÀ¯»ç»óÅÂ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 8 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • plastic state
    Çü¼º»óÅÂ(û¡à÷ßÒ÷¾).
  • platelet immunologic refractory state
    Ç÷¼ÒÆÇ¸é¿ªÇÐÀû ºÒÀÀ»óÅÂ(ÝÕëëßÒ÷¾)
  • postprandial state
    ½ÄÈÄ »óÅÂ
  • preneoplastic state
    Àü¾Ï»óÅÂ(îñäßßÒ÷¾)
  • proliferative state
    Áõ½Ä»óÅÂ
  • reactive nervous state
    ¹ÝÀÀ¼º ½Å°æ°ú¹Î»óÅÂ(ÚãëëàõãêÌèΦÚÂßÒ÷¾).
  • refractory state
    ºÒÀÀ»óÅÂ, ¹«¹ÝÀÀ»óÅÂ
  • relaxation state
    ÀÌ¿Ï »óÅÂ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • lung cancer
    Æó¾Ï
  • lung cancer
    Æó¾Ï(Æó¾Ï).
  • lung cancer
    Æó¾Ï(øË ).
  • mammary cancer
    À¯¾Ï(À¯¾Ï).
  • mammary cancer
    À¯¾Ï(êáäß)
  • maxillary cancer
    »ó¾Ç¾Ï
  • maxillary cancer
    »ó¾Ç¾Ï(ß¾äÉäß)
  • medullary cancer
    ¼öÁú¼º¾Ï(âÐòõàõäß).
  • medullary cancer
    ¼öÁú¼º¾Ï(¡­äß)
  • medullary cancer
    ¼öÁú¼º¾Ï(Ëà̤ËÛËâ).
  • metastatic cancer
    ÀüÀ̼º ¾Ï(¡­äß).
  • metastatic cancer
    ÀüÀ̼º ¾Ï(¡­äß)
  • mucinoid cancer
    Á¡¾×¼º ¾Ï(Á¡¾×¼º¾Ï).
  • mucinoid cancer
    Á¡¾×¼º ¾Ï(ïÄäûàõäß).
  • mule spinner s cancer
    ¸é¹æÀû°ø¾Ï(ËÎËÑËø Ë­Ëâ).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
CFPR Canadian Familial Polyposis Registry
CTR cardiothoracic ratio; carpal tunnel release; central tumor registry
ICRS Index Chemicus Registry System
NRCC National Registry in Clinical Chemistry; National Research Council of Canada
NRM National Registry of Microbiologists; normal range of motion; nucleus reticularis magnocellularis
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 4
MMS Mini Mental State
MMSE Mini Mental State Exam
MMS Mini Mental State Examination
MMSE Mini Mental State Examination
3MS Mini-Mental State
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • immunological deficiency state
    ¸é¿ª °áÇÌ »óÅÂ
  • index of occlusal state
    ±³ÇÕ »óÅ Áö¼ö
  • lacunar state
    ¿­°ø »óÅÂ
  • latent state
    ÀáÀç »óÅÂ
    Àẹ±âÀÇ ±ÕÀÇ »óÅÂ. ±Õ ÀÚ½ÅÀÇ º´Àû Ư¼ºÀ» ¹ßÈÖÇÏÁö ¸øÇϰí ÀÖ´Â »óÅÂ.
  • open state
    °³¹æ »óÅÂ
  • ordinary state
    »óÅÂ
  • paranoid state
    ÆíÁý »óÅÂ
  • partial saturation state
    ºÎºÐ Æ÷È­ »óÅÂ
  • persistent vegetative state
    Áö¼ÓÀû ½Ä¹° »óÅÂ
  • posthypercapnic state
    ÈÄ °úź»êÁõ »óÅÂ
  • relaxation state
    ÀÌ¿Ï »óÅÂ
  • saturation state
    Æ÷È­ »óÅÂ
  • schizophrenic defective state
    ºÐ¿­Áõ °áÇÔ »óÅÂ
    º´¼¼°¡ Á¤ÁöÇÏ¿© Àΰݿ¡ Áö¼ÓÀûÀÎ °áÇÔÀ» ³²±â´Â °æ¿ì.
  • schizophrenic state
    ºÐ¿­ »óÅÂ, Á¤½Å ºÐ¿­ »óÅÂ
  • solid-state laser
    °íü ·¹ÀÌÀú
    °íü ¹°ÁúÀÌ µµÆ÷µÈ º¸Åë ¹Ì·® ¿ø¼Ò·Î °áÁ¤ ¼ÒÁÖ¸¦ Ȱ¼º ¸ÅÁú·Î »ç¿ëÇÏ´Â ·¹ÀÌÀú. 2±Ø Áø°ø°ü ¶Ç´Â ¹ÝµµÃ¼ ·¹ÀÌÀú´Â º¸Åë °íü ·¹ÀÌÀú¶ó´Â Á¤ÀÇ¿¡ ÀûÇÕÇÏÁö¸¸ ÀÌ ±º¿¡¼­ Á¦¿ÜµÈ´Ù.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
triplet state A second excited state of a molecule (e.g., chlorophyll) produced by absorption of light to produce the singlet state, then loss of some energy (fluorescence) to arrive at the longer-lived triplet state The molecule may remain sufficiently long in the triplet state for a second activating light quantum to be effective in producing a "second triplet" state, obviously at still a higher level of excitation, hence reactivity. Alternatively, it may lose the triplet state energy directly and return to the ground state.
(05 Mar 2000)
eunuchoid state An imprecisely delineated condition of a male manifesting signs of inadequate androgen secretion during adolescent growth, regardless of the cause; usually referring to long legs, short trunk, and boyish beardless faces.
(05 Mar 2000)
twilight state A condition of disordered consciousness during which actions may be performed without the conscious volition of the individual and with no memory of such actions.
Compare: somnambulic epilepsy.
(05 Mar 2000)
excited state <chemistry, radiobiology> An atom or nucleus which possesses more energy than its ground state energy.
(16 Dec 1997)
lacunar state The presence of lacunes in the brain. One of the major factors underlying cerebrovascular disease; high correlation with hypertension and atherosclerosis. Symptomatic forms include pure motor hemiplegia and pure hemisensory syndrome; multiple lacunar infarcts are the most common cause of pseudobulbar palsy.
(05 Mar 2000)
local excitatory state Increased irritability of a nerve fibre or muscle fibre which is produced by an ineffective electrical stimulus; summation of the stimuli may occur, resulting in a propagated impulse if two or more subliminal stimuli are applied in rapid succession.
(05 Mar 2000)
American Cancer Society <address, organisation>
American Cancer Society, National Headquarters, 1599 Clifton Road, NE, Atlanta, GA 30329 USA.
Tel: 00 1 404 320-3333
(05 Feb 1998)
bladder cancer The most common warning sign of bladder cancer is blood in the urine. The diagnosis of bladder cancer is supported by findings in the medical history and examination, blood, urine, and X-ray tests, and confirmed with a biopsy (usually during a cystoscope exam). Treatment of bladder cancer depends on the growth, size, and location of the tumour.
(12 Dec 1998)
bladder cancer risks Smoking is a major risk factor. Cigarette smokers develop bladder cancer 2-3 times more often than do nonsmokers. Quitting smoking reduces the risk of bladder cancer, lung cancer, several other types of cancer, and a number of other diseases as well. Workers in some occupations are at higher risk of developing bladder cancer because of exposure to carcinogens (cancer-causing substances) in the workplace. These workers include people in the rubber, chemical, and leather industries, as well as hairstylists, machinists, metal workers, printers, painters, textile workers, and truck drivers.
(12 Dec 1998)
bone cancer <oncology> A general term to imply malignant tumour growth in bone.
(27 Sep 1997)
bovine cancer eye A malignant squamous cell carcinoma of cattle, especially the Hereford breed, that originates in the conjunctival mucous membranes or the surrounding skin; it occurs principally in range cattle having unpigmented skin around the eye and living in regions of intense sunlight.
(05 Mar 2000)
BRCA1 breast cancer susceptibility gene This mutated (changed) version of the BRCA1 gene makes a person susceptible to developing breast cancer.
(12 Dec 1998)
breast cancer <oncology> The uncontrolled growth of malignant breast tissue.
Breast cancer is currently the most common cancer in women and the leading cause of cancer-related death in the 15-54 age group.
Strong risk factors include a prior history for breast cancer or a positive family history for breast cancer.
Early detection is possible through the use of monthly breast self-examination, annual clinical exams and mammography.
WWW: cancerNET document for patients
WWW: cancerNET document for clinicians
(05 Jan 1998)
breast cancer susceptibility genes Inherited factors that predispose to breast cancer. Put otherwise, these genes make one more susceptible to the disease and so increase the risk of developing breast cancer. Two of these genes, BRCA1 and BRCA2, have been identified (and prominently publicised). Several other genes (those for the Li-Fraumeni syndrome, Cowden disease, Muir-Torre syndrome, and ataxia-telangiectasia) are also known to predispose to breast cancer. However, since all of these known breast cancer susceptibility genes together do not account for more than a minor fraction (1/5th at most) of breast cancer that clusters in families, it is clear that more breast cancer genes remain to be discovered.
(12 Dec 1998)
buyo cheek cancer betel cancer
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
  • Mother State
    VirginiaÁÖÀÇ
  • Negro state
    (³²ºÏ ÀüÀï ÀÌÀüÀÇ ³²ºÎÀÇ ³ë¿¹ÁÖ
  • New York State Barge Canal
    ´º¿åÁê ¿îÇϸÁ
  • North Star State
    MinnesotaÁÖÀÇ ¼ÓĪ
  • Nutmeg state
    ¹Ì±¹ ConnecticutÁÖÀÇ ¼ÓĪ
  • Panhandle State
    ¹Ì±¹ ¿þ½ºÆ® ¹öÁö´Ï¾ÆÁÖÀÇ º°Äª
  • Pelican State
    ¹Ì±¹ LouisianaÁÖÀÇ
  • Pine Tree State
    ¹Ì±¹ MainÁÖÀÇ µý À̸§
  • Prairie State
    IllinoisÁÖÀÇ µý À̸§
  • State Department,the
    ±¹¹«¼º
  • State university
    ÁÖ¸³ ´ëÇÐ
  • Sunshine State
    Ç÷θ®´ÙÀÇ ÁÖÀǼÓĪ
  • city-state
    (°í´ë ±×¸®½º µîÀÇ)µµ½Ã ±¹°¡
  • client state
    Á¾¼Ó±¹;ÀÇÁ¸±¹
  • confrontation state
    ÀÎÁ¢ Àû´ë±¹
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 4
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 4
ÅëÇÕ°Ë»ö ¿Ï·á